Event
CECT 3D Printing & Biofabrication Workshop
Friday, November 13, 2020
12:00 p.m.
Virtual - Advanced registration required
Dr. Bhushan Mahadik
mahadikb@umd.edu
https://go.umd.edu/3rd-annual
The University of Maryland's NIBIB/NIH Center for Engineering Complex Tissues (CECT) will host its 3rd annual 3D Printing & Biofabrication Workshop on Friday, November 13th, from 12:00 p.m. – 4:00 p.m. (ET).
This virtual event will introduce attendees to the fundamental concepts of biofabrication as well as more advanced applications of 3D printing in tissue engineering. In addition to CECT speakers, featured guests Dr. Adam Feinberg (Carnegie Mellon) and Dr. Richard Hanna (AstraZeneca) will provide their unique perspectives on the field.
This event is open to the public, but advanced registration is required in order to receive the Zoom login information. Additional information is available online and via a print-ready flyer (PDF). Please see the current agenda below and contact Dr. Bhushan Mahadik with any questions:
| 12:00 – 12:10 p.m. | Welcome & Introductions | Dr. John Fisher (Univ. of Maryland) |
| 12:10 — 12:30 p.m. | A Brief Description of Tissue Engineering & Biofabrication Techniques | Dr. Bhushan Mahadik (Univ. of Maryland) |
| 12:30 — 12:50 p.m. | The 3D Printing Process: Concept to Reality | Robert Choe (Univ. of Maryland) |
| 12:50 — 1:10 p.m. | 3D Printing with Cells & Biologics | Sarah Van Belleghem (Univ. of Maryland) |
| 1:10 — 1:25 p.m. | Break/Q&A with Dr. Mahadik, Chloe, and Van Belleghem | |
| 1:25 — 1:45 p.m. | 3D Printing Strategies for Hard Tissue Scaffolds | Dr. Anthony Melchiorri (Rice University) |
| 1:45 — 2:05 p.m. | Bioink Development & Printability for Complex 3D Printing | Dr. Sang Jin Lee (WFIRM) |
| 2:05 p.m. — 2:25 p.m. | Applications of Bioreactors in Tissue Engineering | Dr. Bhushan Mahadik (Univ. of Maryland) |
| 2:25 — 2:40 p.m. | Break/Q&A with Dr. Melchiorri, Dr. Lee, and Dr. Mahadik | |
| 2:40 — 3:10 p.m | FRESH 3D Printing Across Length-Scales: From Microfluidics to Whole Organs | Dr. Adam Feinberg (Carnegie Mellon) |
| 3:10 — 3:40 p.m | Opportunities & Challenges of Bioprinting — A Drug Discovery Perspective | Dr. Richard Hanna (AstraZeneca) |
| 3:40 — 4:00 p.m | Q&A with Dr. Feinberg and Dr. Hanna | |
